Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Advanced Accelerator Applications amends IPO

    Advanced Accelerator Applications S.A., Saint Genis Pouilly, France Business: Diagnostic, Cancer Date announced: 2015-01-20 Type: IPO To be raised: Up to $80.4 million Shares: 5.4 million Price: $13-$15 Underwriters: …

    Published on 1/26/2015
  • AltheaDx amends IPO

    AltheaDx Inc., San Diego, Calif. Business: Diagnostic, Supply/Service Date announced: 2015-01-23 Type: IPO To be raised: Up to $64.6 million Shares: 4.6 million Price: $12-$14 Underwriters: Citigroup; Jefferies; William…

    Published on 1/26/2015
  • Biocept amends follow-on

    Biocept Inc. (NASDAQ:BIOC), San Diego, Calif. Business: Diagnostic Date announced: 2015-01-21 Type: Follow-on To be raised: Up to $15 million Shares: 6.3 million Price prior: $3.25 Underwriters: Aegis Capital; Feltl …

    Published on 1/26/2015
  • Bone Therapeutics amends IPO

    Bone Therapeutics S.A., Gosselies, Belgium Business: Musculoskeletal Date announced: 2015-01-21 Type: IPO To be raised: Up to EUR28.9 million ($33.4 million) Shares: 1.8 million Price: EUR14.50-EUR16.50 Underwriters: …

    Published on 1/26/2015
  • Flex Pharma amends IPO

    Flex Pharma Inc., Boston, Mass. Business: Neurology Date announced: 2015-01-20 Type: IPO To be raised: Up to $64.6 million Shares: 4.6 million Price: $12-$14 Underwriters: Jefferies; Piper Jaffray; Cantor Fitzgerald; …

    Published on 1/26/2015
  • ImmunoCellular amends follow-on

    ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Calabasas, Calif. Business: Cancer Date announced: 2015-01-21 Type: Follow-on To be raised: Up to $26.5 million Shares: 28.2 million Price prior: $0.85 Underwriter: Roth …

    Published on 1/26/2015
  • Inotek amends IPO

    Inotek Pharmaceuticals Corp., Lexington, Mass. Business: Ophthalmic, Renal, Autoimmune Date announced: 2015-01-22 Type: IPO To be raised: Up to $69.6 million Shares: 4.6 million Price: $13-$15 Underwriters: Cowen; Piper…

    Published on 1/26/2015
  • Inotek amends private placement of senior convertible notes

    Inotek Pharmaceuticals Corp., Lexington, Mass. Business: Ophthalmic, Renal, Autoimmune Date announced: 2015-01-22 Type: Private placement of senior convertible notes To be raised: $30 million Shares: TBD Price: TBD …

    Published on 1/26/2015
  • Spark Therapeutics amends IPO

    Spark Therapeutics Inc., Philadelphia, Pa. Business: Gene/Cell therapy, Ophthalmic, Hematology Date announced: 2015-01-20 Type: IPO To be raised: Up to $93.5 million Shares: 5.5 million Price: $15-$17 Underwriters: …

    Published on 1/26/2015
  • Tracon amends IPO

    Tracon Pharmaceuticals Inc., San Diego, Calif. Business: Cancer Date announced: 2015-01-20 Type: IPO To be raised: Up to $50.4 million Shares: 3.6 million Price: $12-$14 Underwriters: Wells Fargo; Stifel, Nicolaus; …

    Published on 1/26/2015
  • Ablynx completes warrant exercise

    Ablynx N.V. (Euronext:ABLX), Ghent, Belgium Business: Antibodies Date completed: 2015-01-21 Type: Warrant exercise Raised: EUR909,426 ($1.1 million) Shares: 115,946 Price: Not disclosed Shares after offering: 54.1 …

    Published on 1/26/2015
  • Agile Therapeutics completes private placement

    Agile Therapeutics Inc. (NASDAQ:AGRX), Princeton, N.J. Business: Genitourinary, Endocrine/Metabolic Date completed: 2015-01-20 Type: Private placement Raised: $20 million Shares: 3.4 million Price: $5.85 Shares after …

    Published on 1/26/2015
  • Aldeyra Therapeutics completes private placement of common stock and warrants

    Aldeyra Therapeutics Inc. (NASDAQ:ALDX), Burlington, Mass. Business: Autoimmune, Ophthalmic Date completed: 2015-01-20 Type: Private placement of common stock and warrants Raised: $2 million Shares: 211,528 Price: $9.33…

    Published on 1/26/2015
  • Alnylam completes follow-on

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Cancer Date completed: 2015-01-20 Type: Follow-on Raised: $450 million Shares: 4.7 million Price: $95 Shares after …

    Published on 1/26/2015
  • Alnylam completes private placement

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Cancer Date completed: 2015-01-20 Type: Private placement Raised: $61.5 million Shares: 647,448 Price: $95 Shares …

    Published on 1/26/2015
  • Arena completes follow-on

    Arena Pharmaceuticals Inc. (NASDAQ:ARNA), San Diego, Calif. Business: Endocrine/Metabolic, Autoimmune, Cardiovascular Date completed: 2015-01-21 Type: Follow-on Raised: Not disclosed Shares: 21 million Price: Not …

    Published on 1/26/2015
  • Auspex completes follow-on

    Auspex Pharmaceuticals Inc. (NASDAQ:ASPX), La Jolla, Calif. Business: Chemistry, Neurology Date completed: 2015-01-23 Type: Follow-on Raised: $169.5 million Shares: 3 million Price: $56.50 Shares after offering: 30.5 …

    Published on 1/26/2015
  • Autolus completes venture financing

    Autolus Ltd., London, U.K. Business: Cancer Date completed: 2015-01-22 Type: Venture financing Raised: Not disclosed Investor: Syncona Partners LLP Note: Autolus said Syncona committed 30 million ($45.5 million) in a …

    Published on 1/26/2015
  • BioMarin completes follow-on

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Business: Endocrine/Metabolic, Autoimmune, Cancer Date completed: 2015-01-22 Type: Follow-on Raised: $911.5 million Shares: 9.8 million Price: $93.25 Shares …

    Published on 1/26/2015
  • Endo completes private placement of senior notes

    Endo International plc (NASDAQ:ENDP; TSX:ENL), Dublin, Ireland Business: Neurology, Genitourinary Date completed: 2015-01-21 Type: Private placement of senior notes Raised: $1.2 billion Note: The unsecured, …

    Published on 1/26/2015
  • Gecko Biomedical completes venture financing

    Gecko Biomedical S.A.S., Paris, France Business: Dermatology Date completed: 2015-01-20 Type: Venture financing Raised: 1.3 million ($1.5 million) Investor: Bpifrance

    Published on 1/26/2015
  • Genenta Science completes venture financing

    Genenta Science, Milan, Italy Business: Cancer, Gene/Cell therapy Date completed: 2015-01-23 Type: Venture financing Raised: 6.2 million ($7.2 million) Investors: Banca Esperia; Mediolanum; private investors Note: …

    Published on 1/26/2015
  • Innovent Biologics completes venture financing

    Innovent Biologics Inc., Suzhou, China Business: Antibodies, Cancer, Autoimmune Date completed: 2015-01-21 Type: Venture financing Raised: $100 million Investors: Legend Capital; Temasek Capital; Fidelity Biosciences; …

    Published on 1/26/2015
  • Intrexon completes follow-on

    Intrexon Corp. (NYSE:XON), Germantown, Md. Business: Cancer, Agbio/Environmental, Biomanufacturing Date completed: 2015-01-21 Type: Follow-on Raised: $101.3 million Shares: 3.8 million Price: $27 Shares after offering: …

    Published on 1/26/2015
  • Keryx completes follow-on

    Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), New York, N.Y. Business: Endocrine/Metabolic, Renal Date completed: 2015-01-21 Type: Follow-on Raised: $110 million Shares: 9.2 million Price: $12 Shares after offering: 101.…

    Published on 1/26/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993